Drug profile · INN
prolia
prolia is a tumor necrosis factor ligand superfamily member 11 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — prolia
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.70
Quick answer
prolia is a tumor necrosis factor ligand superfamily member 11 inhibitor.
Key facts
INN prolia
Mechanism Tumor necrosis factor ligand superfamily member 11 inhibitor
Target Tumor necrosis factor ligand superfamily member 11
Mechanism of action
Tumor necrosis factor ligand superfamily member 11 inhibitor
Primary target: Tumor necrosis factor ligand superfamily member 11
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prolia?
prolia is a tumor necrosis factor ligand superfamily member 11 inhibitor.